174 related articles for article (PubMed ID: 23850524)
1. Evaluation of anxiolytic-like, anticonvulsant, antidepressant-like and antinociceptive properties of new 2-substituted 4-hydroxybutanamides with affinity for GABA transporters in mice.
Sałat K; Kulig K; Gajda J; Więckowski K; Filipek B; Malawska B
Pharmacol Biochem Behav; 2013 Sep; 110():145-53. PubMed ID: 23850524
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological properties of new GABA uptake inhibitors.
Sałat K; Więckowska A; Więckowski K; Höfner GC; Kamiński J; Wanner KT; Malawska B; Filipek B; Kulig K
Pharmacol Rep; 2012; 64(4):817-33. PubMed ID: 23087134
[TBL] [Abstract][Full Text] [Related]
3. Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties.
Sałat K; Podkowa A; Malikowska N; Kern F; Pabel J; Wojcieszak E; Kulig K; Wanner KT; Strach B; Wyska E
Neuropharmacology; 2017 Feb; 113(Pt A):331-342. PubMed ID: 27771379
[TBL] [Abstract][Full Text] [Related]
4. Analgesic and anticonvulsant activity of new derivatives of 2-substituted 4-hydroxybutanamides in mice.
Sałat K; Kulig K; Sałat R; Filipek B; Malawska B
Pharmacol Rep; 2012; 64(1):102-12. PubMed ID: 22580526
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression.
Sałat K; Podkowa A; Kowalczyk P; Kulig K; Dziubina A; Filipek B; Librowski T
Pharmacol Rep; 2015 Jun; 67(3):465-72. PubMed ID: 25933955
[TBL] [Abstract][Full Text] [Related]
6. 2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
Kowalczyk P; Sałat K; Höfner GC; Guzior N; Filipek B; Wanner KT; Kulig K
Bioorg Med Chem; 2013 Sep; 21(17):5154-67. PubMed ID: 23859778
[TBL] [Abstract][Full Text] [Related]
7. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.
Thoeringer CK; Erhardt A; Sillaber I; Mueller MB; Ohl F; Holsboer F; Keck ME
J Psychopharmacol; 2010 May; 24(5):733-43. PubMed ID: 19346277
[TBL] [Abstract][Full Text] [Related]
8. Analgesic, anticonvulsant and antioxidant activities of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one dihydrochloride in mice.
Salat K; Moniczewski A; Salat R; Janaszek M; Filipek B; Malawska B; Wieckowski K
Pharmacol Biochem Behav; 2012 Mar; 101(1):138-47. PubMed ID: 22227221
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system evaluation of an ethanol extract of Bidens odorata Cav (Asteraceae) leaves, and its antinociceptive interaction with paracetamol and naproxen.
Alonso-Castro AJ; Zapata-Morales JR; Solorio-Alvarado C; Hernández-Santiago A; Espinoza-Ramírez LA; Carranza-Álvarez C; Ramadoss V
Inflammopharmacology; 2020 Jun; 28(3):749-757. PubMed ID: 31754938
[TBL] [Abstract][Full Text] [Related]
10. Search for new potential anticonvulsants with anxiolytic and antidepressant properties among derivatives of 4,4-diphenylpyrrolidin-2-one.
Malawska K; Rak A; Gryzło B; Sałat K; Michałowska M; Żmudzka E; Lodarski K; Malawska B; Kulig K
Pharmacol Rep; 2017 Feb; 69(1):105-111. PubMed ID: 27915183
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.
Kulig K; Więckowski K; Więckowska A; Gajda J; Pochwat B; Höfner GC; Wanner KT; Malawska B
Eur J Med Chem; 2011 Jan; 46(1):183-90. PubMed ID: 21111516
[TBL] [Abstract][Full Text] [Related]
12. Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
Zaręba P; Sałat K; Höfner GC; Łątka K; Bajda M; Latacz G; Kotniewicz K; Rapacz A; Podkowa A; Maj M; Jóźwiak K; Filipek B; Wanner KT; Malawska B; Kulig K
Eur J Med Chem; 2021 Oct; 221():113512. PubMed ID: 34015586
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.
Dalby NO; Thomsen C; Fink-Jensen A; Lundbeck J; Søkilde B; Man CM; Sørensen PO; Meldrum B
Epilepsy Res; 1997 Jul; 28(1):51-61. PubMed ID: 9255599
[TBL] [Abstract][Full Text] [Related]
14. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
Kowalczyk P; Sałat K; Höfner GC; Mucha M; Rapacz A; Podkowa A; Filipek B; Wanner KT; Kulig K
Eur J Med Chem; 2014 Aug; 83():256-73. PubMed ID: 24973660
[TBL] [Abstract][Full Text] [Related]
16. Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.
Rapacz A; Kamiński K; Obniska J; Koczurkiewicz P; Pękala E; Filipek B
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):567-579. PubMed ID: 28188357
[TBL] [Abstract][Full Text] [Related]
17. The four-plates test: anxiolytic or analgesic paradigm?
Ripoll N; Hascoët M; Bourin M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):873-80. PubMed ID: 16644084
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant and antinociceptive activity of new amides derived from 3-phenyl-2,5-dioxo-pyrrolidine-1-yl-acetic acid in mice.
Rapacz A; Obniska J; Wiklik-Poudel B; Rybka S; Sałat K; Filipek B
Eur J Pharmacol; 2016 Jun; 781():239-49. PubMed ID: 27089821
[TBL] [Abstract][Full Text] [Related]
19. First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.
White HS; Watson WP; Hansen SL; Slough S; Perregaard J; Sarup A; Bolvig T; Petersen G; Larsson OM; Clausen RP; Frølund B; Falch E; Krogsgaard-Larsen P; Schousboe A
J Pharmacol Exp Ther; 2005 Feb; 312(2):866-74. PubMed ID: 15550575
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety.
Munro G; Erichsen HK; Mirza NR
Neuropharmacology; 2007 Oct; 53(5):609-18. PubMed ID: 17714743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
